- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 25/20 - HypnoticsSedatives
Patent holdings for IPC class A61P 25/20
Total number of patents in this class: 1472
10-year publication summary
|
50
|
72
|
109
|
93
|
133
|
121
|
149
|
129
|
142
|
41
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Taisho Pharmaceutical Co., Ltd. | 858 |
45 |
| Takeda Pharmaceutical Company Limited | 2718 |
28 |
| Sage Therapeutics, Inc. | 335 |
23 |
| Vanda Pharmaceuticals, Inc. | 382 |
17 |
| Eisai R&D Management Co., Ltd. | 1180 |
17 |
| Axsome Therapeutics, Inc. | 332 |
15 |
| Société des Produits Nestlé S.A. | 10004 |
12 |
| Purdue Pharma L.P. | 494 |
12 |
| Bioxcel Therapeutics, Inc. | 82 |
12 |
| Zevra Therapeutics, Inc. | 96 |
12 |
| Jazz Pharmaceuticals Ireland Limited | 166 |
11 |
| Otsuka Pharmaceutical Co., Ltd. | 1502 |
11 |
| Shionogi & Co., Ltd. | 863 |
11 |
| West China Hospital, Sichuan University | 230 |
11 |
| Daiichi Sankyo Company, Limited | 1886 |
10 |
| Sumitomo Dainippon Pharma Co., Ltd. | 211 |
10 |
| Yangtze River Pharmaceutical (Group) Co., Ltd. | 146 |
10 |
| Mitsubishi Tanabe Pharma Corporation | 425 |
9 |
| Ono Pharmaceutical Co., Ltd. | 420 |
9 |
| Shanghai Haiyan Pharmaceutical Technology Co. Ltd | 109 |
9 |
| Other owners | 1178 |